Where does Avails Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Avails Medical, Inc. ranks #10,550 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Avails Medical, Inc. hold?

Avails Medical, Inc. holds 29 US utility patents granted between 2016 and 2025, spanning 7 technology areas.

What is Avails Medical, Inc.'s Innovation Score?

Avails Medical, Inc. has an Innovation Score of 36.4 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Avails Medical, Inc. focus on?

Avails Medical, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 23 patents, ranking #649 of 7,863 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Avails Medical, Inc.'s patent grant rate increasing or decreasing?

Avails Medical, Inc.'s recent grant velocity is +38% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Avails Medical, Inc.'s patents?

Avails Medical, Inc.'s patents average 12.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Avails Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Avails Medical, Inc.

USPTO PatentsView assignee record - 29 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Avails ranks #10,550 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 7 technology areas.

#10,550
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.4/100): 12.5
avg claims per patent: +38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10550 · US Corporation #10,550 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,550/49,997
PHOTO-FINISH American Orthodontics
CPC-NARROW G01N · 7 areas
INNOV-THIN 36.4/100
CLAIMS-RICH 12.5 claims/avg
TYPE-USCORP US Corporation
VEL-UP +38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: American Orthodontics Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Avails’s 36.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (32%) Velocity 7.8 pts (21%) Breadth 9.4 pts (26%) Claim depth 7.5 pts (21%)

Qualcomm Incorporated · highest

85
Aoyama Seisakusho · near

36
Ablative Solutions · near

36
Avails Medical · this assignee

36
CommScope Telecommun… · near

36
Kount · near

36
3D Lighting… · lowest

7

What this shows Avails's Innovation Score is 36.4/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Avails?

Each dot is one of Avails’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Avails’s own 12.5 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Avails vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Avails's grants concentrate

Avails Medical, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 79.3% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2016. By volume, Avails sits between American Orthodontics Corporation and Beijing Kohler Ltd..

Avails's three-year grant acceleration

Avails Medical, Inc. shows 7 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

American Orthodon…

29
Arisawa MFG

29
Audinate Holdings…

29
Authentic8

29
B & B Metals

29
B&W Group

29
Barnes Group

29
Beijing Kohler

29
Avails Medical ◀

29

What this shows Avails holds 29 patents at rank #10,550, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Avails

By rank, the assignees closest to #10,550 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Avails's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Avails, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Avails ranks #649 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Kount Inc. 36 CommScope Telecommunications (Shanghai) Co. Ltd. 36 Ablative Solutions, Inc. 36 Aoyama Seisakusho Co., Ltd. 36

Avails's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Avails Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	3.4%
2017	2	6.9%
2018	3	10.3%
2019	2	6.9%
2020	1	3.4%
2021	3	10.3%
2022	2	6.9%
2023	1	3.4%
2024	4	13.8%
2025partial year	10	34.5%

Which technologies does Avails Medical, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 16

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 9

A61B - DIAGNOSIS; SURGERY; Identification 4

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

G06F - Electric Digital Data Processing 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Avails Medical, Inc.'s patent record in context - here's where to go next.

Avails Medical, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 79.3% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #10,550 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Avails Medical, Inc. against American Orthodontics Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.